SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bruce wilks who wrote (51)5/5/1997 10:39:00 PM
From: jay a   of 369
 
bruce..urmd is getting ready to launch a marketing campaign aimed at educating consumers. i agree with you, they should be talking to docs like you. anyway, there logic is to have consumers ask there docs similar to claritin strategy. another point; at the present time, patients are not reimbursed by insurance, medicare or medicaid for urmd's product. as i am sure you know, patients are not used to paying for a prescribed product. this is one of the main reasons sales were off from estimates (one use per day vs. predicted two-a-day). they still have about a buck per share in cash ($90 million) and two more products to market. for those with a long-term view, it looks attractive at current prices. also, theyare aggressively working to remedy the reimburesement problem. hope this helps.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext